www.fdanews.com/articles/113877-morphosys-plans-to-advance-proprietary-therapeutic-antibody-pipeline

MorphoSys Plans to Advance Proprietary Therapeutic Antibody Pipeline

January 19, 2009

Biotechnology company MorphoSys AG said it plans to advance and broaden its proprietary therapeutic antibody pipeline in 2009 with its rheumatoid arthritis lead compound MOR103.
RTTNews